Determinants of health-related quality of life: a cross-sectional investigation in physician-managed anticoagulated patients using vitamin K antagonists
Abstract Background Literature has paid little attention in describing the specific contribution of each modifiable and non-modifiable characteristics on health-related quality of life (HRQoL) in physician-managed anticoagulated patients using vitamin K antagonists (VKAs). To describe how patients’...
Main Authors: | Arianna Magon, Cristina Arrigoni, Marco Moia, Michela Mancini, Federica Dellafiore, Duilio F. Manara, Rosario Caruso |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-03-01
|
Series: | Health and Quality of Life Outcomes |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12955-020-01326-y |
Similar Items
-
Non-vitamin k antagonist oral anticoagulants in a European primary care physician survey
by: Claudio Cimminiello, et al.
Published: (2018-08-01) -
Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation
by: Anetta Undas, et al.
Published: (2019-12-01) -
Anticoagulation in sub-saharan africa with the advent of non-vitamin K antagonist oral anticoagulants
by: Raphael Chinedu Anakwue
Published: (2020-01-01) -
Direct Oral Anticoagulants versus Vitamin K Antagonists in Patients Aged 80 Years and Older
by: Patrick Manckoundia, et al.
Published: (2021-04-01) -
Warfarin or non-Vitamin K antagonist oral anticoagulants: Navigating the choice of oral anticoagulant drugs in the COVID-19 pandemic era
by: Heng Cai, et al.
Published: (2020-01-01)